| Line item | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|
| Revenue | $97.06B | $81.32B | $89.31B | $69.19B | $54.49B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $99.01B | $88.23B | $91.87B | $81.43B | $59.57B |
| R&D | – | – | – | – | – |
| SG&A | – | $4.00M | $7.00M | $3.00M | $3.00M |
| Operating Income | $10.06B | $8.30B | -$2.56B | -$12.23B | -$5.08B |
| Interest Expense | $49.60B | $42.05B | $43.07B | $35.67B | $38.28B |
| Tax Expense | $5.44B | $4.00B | $2.56B | $3.90B | $2.90B |
| Net Income | $4.59B | $4.15B | -$5.03B | -$16.13B | -$8.03B |
| EPS (basic) | 10.9200 | 9.9400 | -12.3200 | -40.8200 | -16.1600 |
| EPS (diluted) | 10.8100 | 9.9200 | -12.3200 | -40.8200 | -16.1600 |
| Shares (diluted) | – | – | – | – | $483.92M |